Navigation Links
EXTENDED HEALTH: Noverca Enters the World of Healthcare
Date:4/8/2011

ROME, April 8, 2011 /PRNewswire/ -- Noverca – the first and currently only Italian 'Full MVNO' – has expanded its product offerings by announcing its presence in the Health and Wellness Sector.

An innovative telematic support model to support diabetes treatment has been developed and launched thanks to the long-term partnership between Acotel Group (Parent company of Noverca) and Fatebenefratelli Hospital. Davide Carnevale, Marketing & Sales Director at Noverca Italia, made the announcement during an Italy Expo Comm Italia 2011 press conference.

The telematic support product ensures a constant monitoring solution which enables patients to access their own health activity data on multiple channels including SMS, web, and Smartphone applications, and allows them to share the data with others, including doctors and family, resulting in heightened awareness and overall superior care."The partnership with Fatebenefratelli and the monitoring of diabetic patients is only the first step into the world of Healthcare," said Davide Carnevale.  "Moreover, we are ready to cover many other aspects of the Health and Wellness field."

At the heart of the Noverca system is the patent pending MiniMAU (Management Automation Unit) with embedded SIM Noverca 2.0.  The MiniMAU operates as a patient data access point to the GSM network and interfaces, via either IrDA, Bluetooth, or USB, with medical devices used by patients (e.g. glucometers) while communicating with the central platform.

The platform processes data relating to medical indicators of the patient and provides a full range of analyses useful for diagnostic and management purposes.  If requested, the platform will automatically send alerts via SMS and/or email, thereby permitting healthcare professionals to intervene and modify treatment in real time.

"In addition to our numerous mobile phone services," Davide Carnevale continues, "We will shortly be launching additional 2.0 services in the Health & Wellness, Security and Energy Control management sectors, as well as introducing a new and important concept of social networking."

About Acotel Group: Acotel Group, parent company to Flycell, JinnySoftware, Info2cell, & Noverca Italia, is a global provider of multimedia platforms and applications to mobile network operators and media companies around the world.  Through its customer base, Acotel services more than 35 million end users, and enabled 340 million paid text and multimedia messages in 2002.  Founded in 1992, Acotel operates in 20 countries and is publicly traded on the Milan Stock Exchange.Press OfficePress OfficeCast Adv. & CommunicationCommunication Area - Noverca Italiapressoffice@castadv.it

Alessandro MasciarelliTel.+ 39 06.33252983

alessandro.masciarelli@noverca.itAdriano Conti, Daniela Primerano, Stefania Caucci

Tel. + 39 06.61143000Who is Noverca Italia: Noverca Italia (www.noverca.it) is a company born out of the industrial cooperation starting in 2008 between the Acotel Group and the banking Group Intesa Sanpaolo.  The company is one of the main Italian virtual mobile operators and has always been distinguished by its ability to introduce services with high added value onto the market.


'/>"/>
SOURCE Noverca Italia
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Tris Announces NDA Acceptance of Extended Release Carbinoxamine Oral Suspension for the Treatment of Allergies in Kids Two Years and Older
2. FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents
3. Mylan Receives Approval for First-to-File Generic Sular® Extended-Release Tablets
4. New Study Shows Tapentadol Extended Release (ER) May Significantly Reduce Average Pain Intensity for Diabetic Patients Suffering From Painful Peripheral Neuropathy
5. Shionogi Inc. Announces Commercial Availability of KAPVAY™ (clonidine hydrochloride) Extended-Release Tablets for the Treatment of ADHD
6. Data Suggests Positive Pharmacokinetic Results From Phase I Research of Extended-Release Topiramate
7. Upsher-Smith Laboratories Announces Initiation of Open-Label Extension Study of USL255 (Extended-Release Topiramate) for Adjunctive Treatment of Partial-Onset Epilepsy
8. Actavis Receives Approval of Zolpidem Tartrate Extended-Release Tablets, USP 6.25mg CIV in the U.S. with 180-Day Marketing Exclusivity
9. RoundTable Healthcare Partners Portfolio Company, Argon Medical Devices, Inc., Acquires Critical Care and Extended Dwell Catheter Product Platforms From BD
10. Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain
11. Abbotts SIMCOR ® ( niacin extended-release / simvastatin ) Receives FDA Approval for New Dosage Strengths
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , Oct. 12, 2017 AVACEN Medical ... the company with their  2017 New Product Innovation Award ... on extensive primary and secondary medical device market research by ... through its first-to-market OTC, drug-free pain relief product, the AVACEN ... approach to treating fibromyalgia widespread pain. ...
(Date:10/11/2017)... Oct. 11, 2017  True Health, a leader ... its effort during National Breast Cancer Awareness month ... risks. Research ... calculated that more than 10 million American women ... in BRCA1 or BRCA2 and have not had testing. ...
(Date:10/5/2017)... Oct. 5, 2017  In response to the ... and Maxillofacial Surgeons (AAOMS) released prescribing recommendations that ... be used as a first-line therapy to manage ... Recognizing the value and ... Paper "Opioid Prescribing: Acute and Postoperative Pain Management" ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... The International Association of Eating ... excellence for the field of eating disorders, announces the opening of early registration ... Orlando, Florida at the Omni Resort at ChampionsGate. , The annual ...
(Date:10/13/2017)... LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for care ... is the 90-day elimination period, when the family pays for care, is often waived, ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... will be giving viewers the lowdown on sciatica in a new episode of ... that focuses on current events and innovation and investigates each subject in-depth with ...
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... AccentCare, a leader in post-acute health care, have expanded their existing home health ... Home Health. , AccentCare has been operating a joint venture home health company ...
Breaking Medicine News(10 mins):